| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.07 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |